Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 421,241 | reported | 09 Jun 2025 | tx 1+421,241 |
| Bicara Therapeutics Inc. | 365,130 | reported | 18 May 2026 | tx 49+682,260−412,260 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 15,000 | 3.79 USD | 10b5-1 |
| 18 May 2026 | SALE | Bicara Therapeutics Inc. | 12,022 | 19.96 USD | 10b5-1 |
| 18 May 2026 | SALE | Bicara Therapeutics Inc. | 2,978 | 20.35 USD | 10b5-1 |
| 18 May 2026 | EXERCISE | Bicara Therapeutics Inc. | 15,000 | 0.00 USD | 10b5-1deriv |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,226 | 4.44 USD | |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,454 | 3.79 USD | |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,080 | 5.45 USD | |
| 20 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 15,000 | 3.79 USD | |
| 20 Apr 2026 | SALE | Bicara Therapeutics Inc. | 15,000 | 23.61 USD | |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 8,226 | 0.00 USD | deriv |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,454 | 0.00 USD | deriv |
| 16 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 7,080 | 0.00 USD | deriv |
| 20 Apr 2026 | EXERCISE | Bicara Therapeutics Inc. | 15,000 | 0.00 USD | deriv |
| 20 Mar 2026 | SALE | Bicara Therapeutics Inc. | 1,596 | 18.95 USD | |
| 19 Mar 2026 | SALE | Bicara Therapeutics Inc. | 6,905 | 18.78 USD | |
| 20 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 1,596 | 3.79 USD | |
| 19 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,905 | 3.79 USD | |
| 18 Mar 2026 | SALE | Bicara Therapeutics Inc. | 6,499 | 18.84 USD | |
| 18 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,499 | 3.79 USD | |
| 19 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,905 | 0.00 USD | deriv |
| 18 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 6,499 | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 1,596 | 0.00 USD | deriv |
| 09 Mar 2026 | SALE | Bicara Therapeutics Inc. | 36,766 | 19.17 USD | |
| 09 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 36,766 | 3.79 USD | |
| 09 Mar 2026 | EXERCISE | Bicara Therapeutics Inc. | 36,766 | 0.00 USD | deriv |